Background--The Ross procedure in children carries substantial mortality and reoperation rate. Aortic root dilatation is of concern. To prevent dilatation of the neoaortic root, but permit normal growth, we began to apply an absorbable poly-(pdioxanone)-filaments (PDS) band at the sino-tubular (ST)-junction.
R eplacement of the aortic valve with a pulmonary autograft (Ross procedure) was introduced in the late 1960s, 1 and good results have been reported in both adults [2] [3] [4] and children. [5] [6] [7] [8] [9] [10] However, younger age at the time of the Ross procedure appears to be a risk factor for mortality and reoperation. 11, 12 Progressive neoaortic valve insufficiency (AI) and the need to replace the right ventricular outflow tract (RVOT) conduit in a growing child are key issues. 13 The main concern in children is the dilatation of the neoaortic root, which leads to progression of AI. 14, 15 While stabilization of the aortic root can be achieved in most adult patients, 16, 17 prevention of aortic root dilatation in a growing child can be problematic. To reduce aortic root dilatation and the rate of reoperations on the neoaortic root, we began to apply an absorbable poly-(p-dioxanone)-filaments (PDS) band to stabilize the sino-tubular (ST)-junction. Herein we describe our results with the Ross procedure and midterm outcomes of the ST-junction stabilization technique.
Patients and Methods

Patients
This study was approved by the Human Research Ethics Committee at the Royal Children's Hospital (RCH). All patients who underwent a Ross procedure at the RCH between November 1995 and April 2012 were included in this retrospective study. Medical records were reviewed. Two researchers (S.P.T.T. and R.K.) reviewed all echocardiograms and recorded the diameters of the pulmonary and aortic annulus along with preoperative aortic insufficiency and stenosis. Follow-up echocardiogram reports and letters were obtained from the patients' respective cardiologists. At last follow-up, postoperative autograft measurements and Z-scores 18 were obtained at the annulus, ST-junction, and sinus of valsalva. Early death was defined as death occurring within 30 days of the Ross procedure having been performed or before discharge from the hospital. Patient characteristics are outlined in Table 1 . There were 63 male patients and the mean age at operation was 8.6AE6.1 years (range 3 days to 18 years). There were 6 neonates (≤30 days of age), 13 infants, and 81 children older than 1 year of age.
Operative Techniques
All patients underwent surgery via sternotomy with standard cardiopulmonary bypass (CPB), hypothermia, and antegrade cardioplegia. Median weight at operation was 25.1 kg (range 12.7 to 49 kg) with a mean body surface area of Concomitant procedures were performed in 21 patients, including 1 or more of: mitral valve repair (n=9), aortic arch repair (n=4), subaortic membrane resection (n=4), patent foramen ovale closure (n=2), patent ductus arteriosus ligation (n=2), mitral valve replacement (n=1), left atrial aneurysm repair (n=1), endocardial fibroelastosis resection (n=1), ventral septal defect closure (n=1), relief of subaortic stenosis (n=1), myomectomy (n=1), ascending aorta enlargement (n=1), and atrial septal defect closure (n=1). The repair was assessed intraoperatively with transoesophageal echocardiography. The median length of stay in intensive care unit was 25 hours (IQR 21 to 67 hours) and the median length of hospital stay was 7 days (IQR 6 to 12 days).
Statistical Analysis
All data were analyzed with Stata Statistical Software: Release 10 (StataCorp LP). Descriptive statistics for continuous variables were expressed as meanAEstandard deviation (range), whereas skewed continuous data are presented as medians (interquartile range). A Student's t test was used to compare continuous variables. Categorical variables were summarized as frequencies and percentages. A Fisher's exact test was used to compare categorical or binary variables.
Kaplan-Meier actuarial survival curves were used to analyze and plot time-related endpoints. Association of age at Ross procedure less than 1 year with early mortality and comparison of aortic insufficiency between PDS and control groups was assessed using a chi-squared test and confirmed using a Fisher's exact test. Cox proportional hazards regression analysis was used to identify risk factors for time-related outcomes. Variables tested in the univariate analysis included weight, age, syndrome, isolated aortic stenosis (unicuspid, bicuspid, tricuspid), isolated aortic insufficiency, combined aortic stenosis and insufficiency, endocarditis, rheumatic heart disease, root replacement technique, root inclusion technique, subcoronary technique, Ross-Konno procedure, PDS use, concomitant surgery, bypass time, and cross-clamp time. Of the endpoints examined, due to the number of outcomes, multivariable risk analysis was feasible only for any reoperation. For this endpoint, the number of risk factors included in the model was limited to the 3 most likely predictors from the univariate analysis (due to the limited number of reoperations in total).
Results
Survival
The causes of death are summarized in Table 2 . Early mortality was 6% (6/100), while late mortality was 4.3% (4/94), occurring at 2, 6, 11, and 14 years after the Ross procedure. Overall mortality for the Ross procedure was 10% Other reoperations and reinterventions included mitral valve replacement (n=4), heart transplant (n=1), coronary artery surgery (n=1), and intervention with balloon dilatation (n=5). Four (5%, 4/85) patients required permanent pacemaker implantation after Ross procedure.
Autograft Competency
Among hospital survivors, there were 11 (11.7%, 11/94) patients who developed moderate to severe AI. The KaplanMeier estimate of freedom from greater-than-moderate AI is outlined in Figure 5 . Five patients with moderate to severe AI after Ross procedure underwent reoperation on the aortic valve with good outcomes (3 patients having no AI and 2 patients having trivial AI). At last follow-up, trivial AI was found in 23 patients (25.6%, 23/90), mild AI was found in 25 patients (27.8%, 25/90), moderate or severe AI was found in 6 patients (6.7%, 6/90), and the remaining 36 patients (40%, 36/90) had no AI. Post Ross procedure, aortic dilatation of Z-score >4 was greatest at the ST-junction (23%, 11/48) when compared to the aortic annulus (17%, 11/66) and sinuses (14%, 7/50). Only 6.7% (3/45) had a Z-score >4 in all 3 characteristics. One patient had aortic stenosis.
At our institution, a PDS band was used in 19 patients. We compared them with a control group of 35 patients who underwent the Ross procedure without use of a PDS band (Table 4) . These patients were then evaluated based on age, weight, year of surgery, and length of follow-up. There were no differences between operative mortality (P=0.31), late mortality (P=0. 19) , and neoaortic reoperation (P=0.45). However, there was a reduction in moderate or greater AI (P=0.043) in the PDS group (Table 4) . Kaplan-Meier comparison of AI in PDS versus non-PDS group is shown in Figure 6 .
Follow-Up
Mean follow-up for the 90 survivors was 7.3AE4.8 years (1 month to 16 years). Concurrent follow-up (within the last 3 years) was obtained for 92.2% (83/90) of the patients, and the remainder were lost to follow-up. Of the survivors, 96.7% (87/90) of the patients were in New York Heart Association (NYHA) class 1 and 3.3% (3/90) were in class 2.
Discussion
Although the Ross procedure was initially intended for the treatment of aortic valve disease in adults, 1 it is currently utilized in the pediatric population as well. Herein we reported a 17-year experience at a single institution using the Ross procedure in children. An operative mortality rate of 6% was observed in the present study. This is consistent with other studies in children where operative mortality ranged from 0% to 16%. early mortality in children (4.2%) compared to adults (3.2%).
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In our study, patients younger than 1 year were at a higher risk of early mortality (32%, 6/19). All of the early deaths occurred in the neonatal and infant age group. The patients who died presented in a critical state and necessitated urgent surgery. This is similar to the results reported by Alsoufi et al 11 (n=151, median age of 8.6 years at operation) who identified age younger than 1 year as a predictor of early mortality. In addition, Kadner et al 8 (n=52, median age of 5 years at operation) observed a high early mortality in neonates and infants who presented in poor preoperative condition. Overall, a 10-year survival rate of 91% in our study is comparable to the 90% reported by Horer et al 9 (n=152, median age of 10.1 years at operation). In our study, it appeared that younger and smaller children had worse outcomes, especially those who had preoperative endocarditis.
In this present study, the pulmonary autograft performed well with good intermediate-term durability. Autograft failure leading to AI was the cause of reoperation in all 9 patients. We report a 10-year rate of freedom from aortic valve or root reoperation of 86%, comparable to the 10-year rate reported by Alfousi et al 15 longer follow-up time as a significant risk factor for autograft failure, suggesting that the number of autograft reoperations may increase after the first decade. Increase in aortic root Z-scores with time, suggesting progressive autograft dilatation, is a key concern with the Ross procedure, and has been reported by several authors. 16, 22, 23 The challenge faced in the pediatric population is the potential for AI to develop as the neoaortic root increases in size becoming out of proportion to the somatic growth of the child or young adult. 24 Inclusion, sub-coronary, and reinforcement techniques to improve the durability of the autograft have been utilized in adult populations and mid-term results have been promising. 16, 17, [25] [26] [27] However, stabilization of the neoaortic root that would, at the same time, permit somatic growth is challenging in children. In our study, 40% of patients did not have any AI, 53% had trivial to mild AI and 7% had moderate to severe AI. Consistent estimation of neoaortic root dimensions has been more difficult as most cardiologists, particularly those involved in adult outpatient care, did not record all root dimensions. Nonetheless, from the data available to us, it appears that the most significant root dilatation occurs at the ST-junction. Thus, since 2001, a PDS band was placed around the ST-junction in some patients in an attempt to prevent root dilatation at this level and, hopefully, to minimize subsequent AI. According to the manufacturer's specification, approximately 35% of the PDS band's original strength remains 21 days after implantation. The PDS band subsequently loses all original strength within approximately 50 days and is absorbed after roughly 6 months. This would, theoretically, allow scar formation around the STjunction to stabilize it while allowing subsequent normal growth. The patients were not randomized prospectively to PDS band application, but the PDS band was applied by 2 surgeons as a personal preference. On analysis of our results, the technique did not significantly decrease the rate of autograft reoperation at mid-term follow-up. However, AI was reduced significantly in the PDS group. These results appear promising and further study of the PDS band technique is warranted in order to observe whether the reduction in AI translates into fewer autograft reoperations in the PDS group over time. A weak point of the Ross procedure is the potential for an isolated aortic valve disease to be transformed into a double valve disease. The most common indication for reoperation in this cohort was for replacement of RV-to-PA conduit. As the patients grow, reoperation to replace the conduit can be expected. In our study, freedom from RV-to-PA conduit replacement was 76% at 10 years. This is comparable to the reported 10-year rate of freedom of conduit reoperations of other centers. 5, 10, 15 In the present study, risk factors on univariate analysis for any reoperation included younger age at surgery, lower operative weight, and smaller implanted conduit diameter. This is consistent with Clark et al 10 who reported that patient age and homograft size to influence the longevity of the pulmonary homograft. The findings of smaller homograft size and younger age at operation as risk factors for reoperation are apparent in other pediatric patients undergoing RV-to-PA conduit surgery. 28 At the RCH, the current policy is to delay the Ross procedure until the child is past infancy, if feasible. If the patient requires surgery during infancy, the preference is to perform an initial surgical aortic valve repair. 29 Due to excellent results with aortic valve repair, we tend to reserve Ross operation as the second line of management. The number of aortic valve repairs increased as compared to Ross operations during the recent years. 29, 30 Only patients with small aortic annulus would have Ross procedure without contemplation for an aortic valve repair as initial operation. 29, 30 Thus, postponing the Ross operation until later in childhood or, ideally, into adulthood may minimize both mortality and overall reoperation rates.
Limitations
Our study is retrospective in nature and is limited by its design. Over the study period, surgical and perioperative techniques varied between patients. Although the groups were retrospectively matched, the selection of patients who underwent PDS banding was not prospectively randomized. Dimensions of the neoaortic root were not available in all patients.
Conclusion
The Ross procedure in children can be performed with acceptable results. Children younger than 1 year of age have higher mortality, but not an increased autograft reoperation rate. Stabilization of the ST-junction may reduce AI. The majority of patients are asymptomatic at last follow-up. A smaller homograft inserted at the Ross procedure is a significant predictor for reoperation.
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